InvestorsHub Logo
Followers 74
Posts 3601
Boards Moderated 0
Alias Born 03/23/2013

Re: rosemountbomber post# 408338

Sunday, 05/07/2023 7:33:38 AM

Sunday, May 07, 2023 7:33:38 AM

Post# of 425933
I have made it perfectly clear what my opinion was regarding Sarissa’s trading activity. The timing of the announcement of a proxy war just as the new year began, tax loss selling was complete, on the eve of the annual biotech conference, on the heels of a ridiculous and questionable analyst upgrade. That was part 1 of the plan; induce a rally up to the down TL.
part 2 was to short at this falling resistance, remain silent, allow chaos to ensue (in the form of complete BOD resignation) and then cover near the bottom as prices fill the gap.

Now, with a 98% gain up and 44% swoon, they have managed to lower their initial purchase cost, gain 100% control, and put Amarin up for a substantially reduced price tag - to the chagrin of retail bag holders with an avg cost basis in the double digits.
Sure the price could spring higher than expected off this bottom pattern, but Sarissa is no longer hungry to roll up their sleeves and make the necessary strategic improvements to attract a higher bid. Who knows how low they’ll go. Current shareholders do not consist of fresh higher high hopeful institutions. They consist of underwater shareholders who want out at any cost, hence they’ll vote in favor of a cheap buyout.
That’s my opinion. That’s been P-Dude’s opinion and so far it has unfolded exactly as outlined.
Those who argue against this sequela have no facts, or convincing argument - hence they resort to mud slinging.

There, is that detail better?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News